Troy, MI – January 15, 2026 – MediVera Compounding Pharmacy is pleased to announce that we are now licensed to serve healthcare providers and patients in the District of Columbia and the State of Nevada. As of January 15, 2026, providers in these jurisdictions may prescribe our comprehensive range of compounded medications to their patients, supported by over two decades of compounding expertise.
A Message from Our CEO
“Expanding into the District of Columbia and Nevada is an exciting step forward in our mission to bring personalized medicine to more communities nationwide,” says CEO Bradley McCloskey, PharmD. “These new licenses mean thousands of additional patients and providers now have access to truly individualized care. We remain dedicated to the vision established over 25 years ago: that every patient deserves medications tailored specifically to their unique needs. We’re honored to now serve healthcare professionals and patients in our nation’s capital and the Silver State.”
With the addition of the District of Columbia and the state of Nevada, MediVera now serves patients in 45 states: AK, AZ, CO, CT, DC, DE, FL, GA, ID, IL, IA, IN, KS, KY, LA, ME, MD, MA, MI, MN, MO, MT, NE, NV, NH, NJ, NM, NY, NC, ND, OH, OK, OR, PA, RI, SC, SD, TN, TX, UT, VA, VT, WA, WV, WI, WY.
Clinical Solutions for Your Practice
MediVera provides expertly compounded medications when commercially manufactured products are unavailable, discontinued, or unsuitable for a patient’s unique needs. We specialize in:
- Hormone Replacement Therapy
- Sexual Health
- Weight Management
- Longevity
- Dermatology
- Pet Medications
Our pharmacy holds PCAB (Pharmacy Compounding Accreditation Board) accreditation in both sterile and non-sterile compounding—a rigorous distinction achieved by fewer than 1% of compounding pharmacies nationwide. This accreditation reflects our unwavering commitment to quality and consistency.
Every formulation is prepared in our state-of-the-art facility using premium ingredients sourced exclusively from FDA-registered suppliers. We adhere strictly to USP <795>, <797>, and <800> guidelines.
To guarantee the highest standards, MediVera invests more than $60,000 monthly in independent third-party testing, verifying the potency, purity, sterility, and stability of every compounded medication we dispense.
MediVera’s Streamlined Prescribing Process
- Standard prescription submission via fax, phone, e-scribe, or our Provider Portal
- Telehealth fulfillment services to support remote patient care
- Direct provider-to-pharmacist consultation available for complex cases
- Medications shipped directly to patients’ homes across all licensed states
- Insurance verification and prior authorization support when applicable
- Ongoing support for dosage adjustments and monitoring
- Patient counseling services to ensure proper understanding of compounded medications
Partner with MediVera
We welcome healthcare providers—including physicians, nurse practitioners, physician assistants, and other licensed prescribers—in the District of Columbia, Nevada, and all our licensed jurisdictions to utilize our compounding services. A prescription from a licensed prescriber is required for all compounded medications to be dispensed.
Our company’s proprietary customer service program—The Impressed Advantage by MediVera Compounding Pharmacy™—includes fast shipping, dedicated account management, clinical education, and patient-first prescription fulfillment.
